JPRN-UMIN000011349
Completed
未知
Assessment for efficacy of combination therapy with Chinese herbal medicine "Shin-bu-to" for Clostridium difficile infection. - Efficacy of "Shin-bu-to" combination therapy for Clostridium difficile infection.
ConditionsClostridium difficile infection.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Clostridium difficile infection.
- Sponsor
- Yokohama City University Medical Center
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Shock status. Conscious disturbance. Needs intensive care. Unable to take drugs orally due to interstitial dysfunction. Recurrent case of Clostridium difficile infection.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
The effect of erythropoietin on acute spinal cord injuryTraumatic Cervical Spinal Cord Injury.Injury of nerves and spinal cord at neck levelIRCT20180923041103N1Mashhad University of Medical Sciences54
Recruiting
Phase 3
Evalution of the effect of combination therapy with extract of Bunium Persicum and Foeniculum Vulgare on clinical features in Polycystic Ovary Syndrome (PCOS) patientsPcos.Polycystic ovarian syndromeIRCT20120709010222N20Research Deputy of Shahrekord University of Medical Sciences70
Completed
Not Applicable
A study on the efficacy of combination therapy of insulin and ipragliflozin in patients with type 2 diabetesJPRN-UMIN000014798Imamura clinic15
Not yet recruiting
Phase 2
Comparison between chlorpromazine with olanzapine vs chlorpromazine alone in the treatment of hiccups in patients who had traumatic brain injuryHealth Condition 1: G998- Other specified disorders of nervous system in diseases classified elsewhereHealth Condition 2: G998- Other specified disorders of nervous system in diseases classified elsewhereCTRI/2020/11/028823Trauma centre Banaras Hindu University
Recruiting
Not Applicable
Clinical investigation of combination therapy with a1 blocker and vibegron for treating overactive bladder in patients with benign prostatic hyperplasiaoveractive bladderJPRN-UMIN000039150Koto Hospital, Dept. of Urology50